GNI Group Logo

GNI Group

🇯🇵
2160
JP3386370005

GNI Group, headquartered in Japan, is a leading biopharmaceutical company specializing in the research, development, and commercialization of innovative medicines. The company focuses on treating inflammatory diseases and fibrosis through the advancement of novel therapeutic agents.

Next Quarterly Earnings

Monday, November 16, 2026
CW 47
Pre-Market
In 81 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on October 19, 2026

Stock Price

Frequently asked questions

When will GNI Group report its next quarterly earnings?

GNI Group is scheduled to report its next quarterly earnings on 11/16/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did GNI Group last report quarterly earnings?

GNI Group last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at 2.54 JPY.

How often has GNI Group beaten expectations?

GNI Group has beaten analyst EPS estimates in 1 of its last 3 evaluated quarters (beat rate: 33.3%).

How do I add the GNI Group earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:¥27.30
Actual:
Q2 2026
Beat
Estimate:-¥2.63
Actual:¥2.54
Difference:+¥5.17
Q1 2026
Missed
Estimate:-¥2.74
Actual:-¥38.20
Difference:-¥35.46
Price reaction (1 day):-2.0 %
Price reaction (7 days):-6.0 %
Q4 2025
Missed
Estimate:¥224.64
Actual:-¥74.44
Difference:-¥299.08
Price reaction (1 day):-3.5 %
Price reaction (7 days):+12.2 %

Earnings statistics

Estimates vs. results

1/3
Quarters above estimates
33.3%
Beat rate
-410.2%
Avg. EPS surprise

Basis: 3 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
GNI Group
Ticker Symbol
2160
ISIN
JP3386370005
Country
🇯🇵
Japan
Sector
More Financial Information